Johnson & Johnson (JNJ) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Johnson & Johnson Revenue Highlights

Latest Revenue (Y)

$94.19B

Latest Revenue (Q)

$23.99B

Main Segment (Y)

Innovative Medicine

Main Geography (Y)

UNITED STATES

Johnson & Johnson Revenue by Period

Johnson & Johnson Revenue by Year

Date	Revenue	Change
2025-12-28	$94.19B	6.05%
2024-12-29	$88.82B	4.30%
2023-12-31	$85.16B	6.46%
2023-01-01	$79.99B	1.59%
2022-01-02	$78.74B	-4.65%
2021-01-03	$82.58B	0.64%
2019-12-31	$82.06B	0.59%
2018-12-31	$81.58B	6.71%
2017-12-31	$76.45B	6.34%
2016-12-31	$71.89B	2.59%
2015-12-31	$70.07B	-5.73%
2014-12-31	$74.33B	4.23%
2013-12-31	$71.31B	6.08%
2012-12-31	$67.22B	3.37%
2011-12-31	$65.03B	5.59%
2010-12-31	$61.59B	-0.50%
2009-12-31	$61.90B	-2.90%
2008-12-31	$63.75B	4.34%
2007-12-31	$61.09B	14.57%
2006-12-31	$53.32B	5.56%
2005-12-31	$50.51B	6.69%
2004-12-31	$47.35B	13.10%
2003-12-31	$41.86B	15.33%
2002-12-31	$36.30B	12.32%
2001-12-31	$32.32B	10.78%
2000-12-31	$29.17B	4.16%
1999-12-31	$28.01B	16.72%
1998-12-31	$24.00B	6.04%
1997-12-31	$22.63B	4.67%
1996-12-31	$21.62B	14.74%
1995-12-31	$18.84B	19.75%
1995-01-01	$15.73B	11.29%
1994-01-02	$14.14B	-

Johnson & Johnson generated $94.19B in revenue during NA 2025, up 6.05% compared to the previous quarter, and up 114.06% compared to the same period a year ago.

Johnson & Johnson Revenue by Quarter

Date	Revenue	Change
2025-09-28	$23.99B	1.05%
2025-06-29	$23.74B	8.45%
2025-03-30	$21.89B	-2.78%
2024-12-31	$22.52B	0.22%
2024-09-29	$22.47B	0.11%
2024-06-30	$22.45B	4.98%
2024-03-31	$21.38B	-0.06%
2023-12-31	$21.39B	0.21%
2023-10-01	$21.35B	-0.78%
2023-07-02	$21.52B	2.99%
2023-04-02	$20.89B	-11.86%
2022-12-31	$23.71B	18.55%
2022-10-02	$20.00B	-16.75%
2022-07-03	$24.02B	2.54%
2022-04-03	$23.43B	-5.56%
2021-12-31	$24.80B	6.28%
2021-10-03	$23.34B	0.11%
2021-07-04	$23.31B	4.44%
2021-04-04	$22.32B	-0.69%
2020-12-31	$22.48B	6.61%
2020-09-27	$21.08B	14.98%
2020-06-28	$18.34B	-11.38%
2020-03-29	$20.69B	-0.27%
2019-12-31	$20.75B	0.09%
2019-09-29	$20.73B	0.81%
2019-06-30	$20.56B	2.70%
2019-03-31	$20.02B	-1.83%
2018-12-31	$20.39B	0.23%
2018-09-30	$20.35B	-2.31%
2018-07-01	$20.83B	4.10%
2018-04-01	$20.01B	-0.92%
2017-12-31	$20.20B	2.77%
2017-10-01	$19.65B	4.30%
2017-07-02	$18.84B	6.04%
2017-04-02	$17.77B	-1.88%
2017-01-01	$18.11B	1.60%
2016-10-02	$17.82B	-3.58%
2016-07-03	$18.48B	5.72%
2016-04-03	$17.48B	-1.85%
2016-01-03	$17.81B	4.15%
2015-09-27	$17.10B	-3.85%
2015-06-28	$17.79B	2.38%
2015-03-29	$17.37B	-4.82%
2014-12-28	$18.25B	-1.15%
2014-09-28	$18.47B	-5.27%
2014-06-29	$19.50B	7.62%
2014-03-30	$18.11B	-1.31%
2013-12-29	$18.36B	4.44%
2013-09-29	$17.57B	-1.69%
2013-06-30	$17.88B	2.13%
2013-03-31	$17.50B	-0.30%
2012-12-30	$17.56B	2.97%
2012-09-30	$17.05B	3.50%
2012-07-01	$16.48B	2.08%
2012-04-01	$16.14B	-0.71%
2012-01-01	$16.25B	1.56%
2011-10-02	$16.00B	-3.57%
2011-07-03	$16.60B	2.62%
2011-04-03	$16.17B	3.38%
2011-01-02	$15.64B	4.42%
2010-10-03	$14.98B	-2.27%
2010-07-04	$15.33B	-1.93%
2010-04-04	$15.63B	-5.56%
2010-01-03	$16.55B	9.75%
2009-09-27	$15.08B	-1.04%
2009-06-28	$15.24B	1.42%
2009-03-29	$15.03B	-1.03%
2008-12-28	$15.18B	-4.64%
2008-09-28	$15.92B	-3.22%
2008-06-29	$16.45B	1.58%
2008-03-30	$16.19B	1.49%
2007-12-30	$15.96B	-

Johnson & Johnson generated $23.99B in revenue during Q3 2025, up 1.05% compared to the previous quarter, and up 106.89% compared to the same period a year ago.

Johnson & Johnson Revenue Breakdown

Johnson & Johnson Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Jan 23
MedTech	$33.79B	$31.86B	$30.40B	$27.43B
Innovative Medicine	$60.40B	$56.96B	-	-
INNOVATIVE MEDICINE	-	-	-	-
Consumer	-	-	-	$14.95B
Pharmaceutical	-	-	-	$52.56B

Johnson & Johnson's latest annual revenue breakdown by segment (product or service), as of Dec 25: Innovative Medicine (64.12%), and MedTech (35.88%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21
MedTech	$8.80B	$8.43B	$8.54B	$8.02B	$8.19B	$7.89B	$7.96B	$7.82B	$7.67B	$7.46B	-	-	-	-	-	-	-	-	-	-
Innovative Medicine	$15.76B	$15.56B	$15.20B	$13.87B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
INNOVATIVE MEDICINE	-	-	-	$13.87B	$14.58B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pharmaceutical	-	-	-	-	-	-	-	-	-	-	$13.73B	-	-	-	-	-	-	-	-	-
Medical Devices	-	-	-	-	-	-	-	-	-	-	$7.79B	-	-	-	-	-	-	-	-	-
Consumer	-	-	-	-	-	-	-	-	-	-	$4.01B	$3.85B	$3.77B	$3.79B	$3.81B	$3.59B	$3.66B	$3.70B	$3.73B	$3.54B

Johnson & Johnson's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Innovative Medicine (64.17%), and MedTech (35.83%).

Johnson & Johnson Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Jan 23	Jan 22
UNITED STATES	$53.75B	$50.30B	$46.44B	$48.58B	$47.16B
Western Hemisphere, excluding U.S.	$4.88B	$4.71B	$4.55B	$6.13B	-
Asia-Pacific, Africa	$14.03B	$13.59B	$13.76B	$16.79B	$17.27B
Europe	$21.54B	$20.21B	$20.41B	$23.45B	$23.59B

Johnson & Johnson's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (57.07%), Europe (22.86%), Asia-Pacific, Africa (14.90%), and Western Hemisphere, excluding U.S. (5.18%).

Quarterly Revenue by Country

Country	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Oct 23	Jul 23	Apr 23	Oct 22	Jul 22	Apr 22	Oct 21	Jul 21	Apr 21	Sep 20	Jun 20	Mar 20
Asia-Pacific, Africa	$3.50B	$3.61B	$3.61B	$3.31B	$3.26B	$3.48B	$3.45B	$3.41B	$3.46B	$4.48B	$4.31B	$4.25B	$4.20B	$4.51B	$4.29B	$4.36B	$4.37B	$3.88B	$3.60B	$3.66B
UNITED STATES	$27.90B	$13.54B	$38.68B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Western Hemisphere, excluding U.S.	$1.27B	$1.23B	$1.21B	$1.17B	$1.14B	$1.17B	$1.21B	$1.19B	$1.17B	$1.71B	-	-	-	-	-	-	-	-	-	-
Europe	$5.60B	$5.44B	$5.39B	$5.11B	$4.92B	$4.91B	$5.21B	$5.16B	$4.73B	$5.89B	$6.33B	$5.52B	$6.08B	$6.02B	$5.59B	$5.67B	$5.41B	$4.82B	$4.06B	$4.83B

Johnson & Johnson's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (72.91%), Europe (14.63%), Asia-Pacific, Africa (9.15%), and Western Hemisphere, excluding U.S. (3.32%).

Johnson & Johnson Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
UNH	UnitedHealth Group	$447.57B	$113.16B
NVO	Novo Nordisk	$232.26B	$65.35B
JNJ	Johnson & Johnson	$94.19B	$23.99B
MRK	Merck	$65.01B	$17.28B
PFE	Pfizer	$62.58B	$16.65B
ABBV	AbbVie	$61.16B	$15.78B
AZN	AstraZeneca	$54.07B	$15.19B
NVS	Novartis	$46.66B	$11.83B
SNY	Sanofi	$43.07B	$11.12B
AMGN	Amgen	$36.75B	$9.56B
GILD	Gilead Sciences	$29.44B	$7.77B

JNJ Revenue FAQ

What is Johnson & Johnson’s yearly revenue?

Johnson & Johnson's yearly revenue for 2025 was $94.19B, representing an increase of 6.05% compared to 2024. The company's yearly revenue for 2024 was $88.82B, representing an increase of 4.30% compared to 2023. JNJ's yearly revenue for 2023 was $85.16B, representing an increase of 6.46% compared to 2022.

What is Johnson & Johnson’s quarterly revenue?

Johnson & Johnson's quarterly revenue for Q3 2025 was $23.99B, a 1.05% increase from the previous quarter (Q2 2025), and a 6.77% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $23.74B, a 8.45% increase from the previous quarter (Q1 2025), and a 5.77% increase year-over-year (Q2 2024). JNJ's quarterly revenue for Q1 2025 was $21.89B, a -2.78% decrease from the previous quarter (Q4 2024), and a 2.39% increase year-over-year (Q1 2024).

What is Johnson & Johnson’s revenue growth rate?

Johnson & Johnson's revenue growth rate for the last 3 years (2023-2025) was 10.61%, and for the last 5 years (2021-2025) was 19.63%.

What are Johnson & Johnson’s revenue streams?

Johnson & Johnson's revenue streams in c 25 are MedTech, and Innovative Medicine. MedTech generated $33.79B in revenue, accounting 35.88% of the company's total revenue, up 6.07% year-over-year. Innovative Medicine generated $60.4B in revenue, accounting 64.12% of the company's total revenue, up 6.03% year-over-year.

What is Johnson & Johnson’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Johnson & Johnson was Innovative Medicine. This segment made a revenue of $60.4B, representing 64.12% of the company's total revenue.